Alvotech Scientific Officer Describes Company's Global Biosimilars Strategy
November 25, 2020
Tony Hagen
ArticleJoseph E. McClellan, PhD, MBA, discussed navigation of regulatory hurdles as the company continues its quest to line up distribution partnership deals across the globe.